Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Interest & Investment Income: 2012-2023

Historic Interest & Investment Income for RedHill Biopharma (RDHL) over the last 11 years, with Jun 2023 value amounting to $7.1 million.

  • RedHill Biopharma's Interest & Investment Income rose 326.90% to $7.1 million in Q2 2023 from the same period last year, while for Jun 2023 it was $40.6 million, marking a year-over-year increase of 2284.89%. This contributed to the annual value of $8.4 million for FY2024, which is 59.78% down from last year.
  • Latest data reveals that RedHill Biopharma reported Interest & Investment Income of $7.1 million as of Q2 2023, which was down 67.13% from $21.6 million recorded in Q1 2023.
  • In the past 5 years, RedHill Biopharma's Interest & Investment Income registered a high of $21.6 million during Q1 2023, and its lowest value of -$214,000 during Q1 2020.
  • Its 3-year average for Interest & Investment Income is $4.2 million, with a median of $852,000 in 2021.
  • Per our database at Business Quant, RedHill Biopharma's Interest & Investment Income crashed by 157.22% in 2020 and then soared by 215,720.00% in 2023.
  • RedHill Biopharma's Interest & Investment Income (Quarterly) stood at $260,000 in 2019, then crashed by 126.54% to -$69,000 in 2020, then surged by 117.39% to $12,000 in 2021, then soared by 72,400.00% to $8.7 million in 2022, then surged by 326.90% to $7.1 million in 2023.
  • Its Interest & Investment Income stands at $7.1 million for Q2 2023, versus $21.6 million for Q1 2023 and $8.7 million for Q4 2022.